[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636968":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":33,"locations":41,"responsibleParty":61,"collaborators":25,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":25,"eligibilityCriteria":69,"healthyVolunteers":70,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":25,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":25,"overallStatus":83,"whyStopped":25,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Radicle Science","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo Control","PLACEBO_COMPARATOR","Fatigue Product Placebo Control",[13],"Dietary Supplement: Fatigue Product Placebo Control",{"label":15,"type":16,"description":17,"interventionNames":18},"Active Product 1","EXPERIMENTAL","Fatigue Active Product 1",[19],"Dietary Supplement: Fatigue Active Product 1",[21,26],{"type":22,"name":11,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","Participants will use their Fatigue Product Placebo Control as directed for a period of 6 weeks.",[9],null,{"type":22,"name":17,"description":27,"armGroupLabels":28,"otherNames":25},"Participants will use their Fatigue Active Product 1 as directed for a period of 6 weeks.",[15],[30],{"name":31,"affiliation":5,"role":32},"Susan Hewlings","PRINCIPAL_INVESTIGATOR",[34,39],{"name":35,"role":36,"phone":37,"phoneExt":25,"email":38},"Study Manager","CONTACT","858-779-0086","studymgmt@radiclescience.com",{"name":31,"role":36,"phone":25,"phoneExt":25,"email":40},"susan.hewlings@radiclescience.com",[42],{"facility":43,"status":25,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Radicle Science Inc.","Del Mar","California","92014","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-117.26531,32.95949,{"lat":53,"lon":52},[56,58],{"name":35,"role":36,"phone":57,"phoneExt":25,"email":38},"760-281-3898",{"name":59,"role":36,"phone":25,"phoneExt":25,"email":60},"Megan Mosely1","megan@radiclescience.com",{"type":62,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100636968","radicle-womens-healthtm-a-study-assessing-the-impact-of-health-and-wellness-products-on-fatigue-and-related-health-outcomes-among-women-experiencing-menopausal-symptoms-100636968",false,"NCT07572578","Radicle Women's HealthTM: A Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes Among Women Experiencing Menopausal Symptoms","Radicle Women's HealthTM: A Randomized, Double-Blind, Placebo- Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Fatigue and Related Health Outcomes Among Women Experiencing Menopausal Symptoms","3.1 Inclusion\n\nParticipants must meet all the following criteria:\n\n* Adults, 35-60 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities\n\n  * Assigned sex at birth is female\n* Experience at least two menopausal symptoms\n* Resides in the United States\n* Has the opportunity for at least 30% improvement in their primary health outcome\n* Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study\n\n3.2 Exclusion\n\nIndividuals who report any of the following during screening may be excluded from participation:\n\n* Report being pregnant, trying to become pregnant, or breastfeeding\n* Unable to provide a valid US shipping address and mobile phone number\n* Reports current enrollment in another clinical trial\n* Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)\n* Unable to read and understand English at a 7th grade level\n* Reports a current and\u002For recent (up to 3 months ago) major illness and\u002For surgery that poses a known, significant safety risk.\n* Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and\u002For a significant safety risk with any of the study product ingredients.\n\n  * NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure\n* Reports taking medications that have a well-established moderate or severe interaction, posing a substantial safety risk with any of the study product ingredients.\n\n  * Anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications that warn against grapefruit consumption, corticosteroids at doses greater than 5 mg per day, diabetic medications, oral anti-infectives (antibiotics, antifungals, antivirals) to treat an acute infection, antipsychotics, MAOIs, or thyroid products\n* Reports current use of the primary ingredient(s) and\u002For similar product(s) to the active study product(s) that may limit the effects of the study products and\u002For pose a safety risk\n* Lack of reliable daily access to the internet\n* Reports surgical menopause\u002Fbilateral oophorectomy\n* Reports taking HRT or prescription menopausal products",true,"FEMALE","35 Years","60 Years",{"count":75,"type":76},550,"ESTIMATED","INTERVENTIONAL",[79],"NA","Radicle Women's HealthTM: A randomized, double-blind, placebo- controlled direct-to-consumer study assessing the impact of health and wellness products on fatigue and related health outcomes among women experiencing menopausal symptoms.",[82],"Fatigue","NOT_YET_RECRUITING","2026-05-01",{"date":86,"type":87},"2026-05-07","ACTUAL",{"date":89,"type":76},"2026-05-11",{"date":91,"type":76},"2027-05-11",{"name":5,"class":6},1]